 |
Joele Frank handles Crinetics Pharmaceuticals as the specialist for treatments for endocrine diseases agrees to be acquired by Vertex Pharmaceuticals in a deal pegged at $8.8B.
Crinetics’ Palsonify medicine is the first and only once-daily oral therapy for a debilitating condition caused by a pituitary tumor that secretes excess growth hormone. It received approval from the FDA in September 2025 and was recently okayed by the European Medicines Agency.
Reshma Kewalramani, Vertex CEO, called Crinetics an excellent strategic fit “with its focus on serious diseases in specialty markets with significant unmet need, well-understood causal human biology, and potentially best-in-class medicines that could deliver transformative benefit to patients.”
Joele Frank, Wilkinson Brimmer Katcher partners Jamie Moser and Jed Repko, and managing directors Catherine Simon and Fouad Boutros represent Crinetics.
Throughline Global Advisors represents Principal Mineral as it acquires Conductive Group, manufacturer of advanced materials for the aerospace, telecommunications and electronics sectors.
Trump Media & Technology Group posted a $238M Q2 loss on $1.7M in revenues. That performance compares to a $20M loss and $883K revenues in the 2025 comparable quarter.
The Brand Amp represents Archer Aviation as it acquires Boeing’s $200M flying-taxi operation in return for a 20 percent stake in the Silicon Valley startup.
Amsterdam’s CFF Communications handles Accell Group as Europe’s No 1 e-bike and No. 2 bicycle maker declares insolvency after failing to find a buyer.
Randy Sinclair, who rose to lead investor relations at Chevron during an 11-year run, will move to Northrop Grumman on Aug. 10 as VP-IR.
